The Science behind Lit-Control
Lit-Control is formulated with ingredients that have been studied for their ability to help maintain a healthy urinary pH, reduce kidney stone crystallisation, and support overall kidney health.
Lit-Control is formulated with ingredients that have been studied for their ability to help maintain a healthy urinary pH, reduce kidney stone crystallisation, and support overall kidney health.
Lit-Control Explained: How It Works
Specifically formulated to support healthy kidney function and may inhibit calcium stones
Specifically formulated to increase urinary pH and maintain urinary health
Specifically formulated to decrease urinary pH and maintain urinary health
Clinical Studies on Lit-Control Regulating Urinary pH and its ingredients Inhibiting Crystallisation
Lit-Control pH Up
Monitoring and nutraceutical intervention for a non-lithogenic pH range
Lit-Control pH Up has been shown to be effective in urinary pH regulation with significant changes in controls at 30, 60 and 90 days compared to the baseline visit.
Lit-Control pH Down
Monitoring and nutraceutical intervention for a non-lithogenic pH range
Lit-Control pH Down has been shown to be effective in urinary pH regulation with significant changes in controls at 30, 60 and 90 days compared to the baseline visit.
Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine
The synergistic effect between magnesium and phytate on calcium oxalate crystallization suggests that a combination of these two compounds may be highly useful as anti lithiasis therapy.
Lit-Control Conference: Scientific Presentations
Dr Juan Antonio Galán
Head of the Department of Urology, General University Hospital Alicante, Spain & EULIS Board Member
Importance of pH management and crystallisation inhibition – new solutions in kidney stone prevention
Mr Rosendo Garganta
CEO, Devicare
Lit-Control: A complete range to treat and prevent kidney stones & the importance of the management of urinary pH for other pathologies i.e. recurrent UTIs
Prof Rustom Manecksha
Consultant Urological Surgeon at Tallaght University Hospital, St. James’s Hospital & Beacon Hospital
Chairing this Scientific Session’s Q&A Discussion